Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 11,111,111 shares of APLS stock, worth $426 Million. This represents 7.87% of its overall portfolio holdings.
Number of Shares
11,111,111
Previous 11,111,111
-0.0%
Holding current value
$426 Million
Previous $665 Million
1.8%
% of portfolio
7.87%
Previous 9.48%
Shares
11 transactions
Others Institutions Holding APLS
# of Institutions
337Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$578 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$436 Million19.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$211 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.61MShares$177 Million0.17% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.21B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...